≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other papulosquamous disorders

EFO MESH Endpoint Browser PheWeb

L12_PAPULOSQUAOTH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L44
  • Cause of death: ICD-10 — L44

2 out of 7 registries used, show all original rules.

308

4. Check minimum number of events

None

308

5. Include endpoints

398

6. Filter based on genotype QC (FinnGen only)

398

Control definitions (FinnGen only)

Control exclude
L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L40-L45
Name in latin
Aliae morbositates papulosquamosae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3924 2160 1732
Only index persons 3067 1745 1322
Unadjusted period prevalence (%)
Whole population 0.06 0.06 0.05
Only index persons 0.06 0.06 0.05
Median age at first event (years)
Whole population 43.28 46.71 38.85
Only index persons 41.53 44.89 37.09

-FinnGen-

Key figures

All Female Male
Number of individuals 398 233 165
Unadjusted period prevalence (%) 0.08 0.08 0.07
Median age at first event (years) 49.32 44.57 56.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
360
Matched controls
3598
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L44.0
ICD-10 Finland
Pityriasis rubra pilaris
+∞
76.9
71
*
L44.8
ICD-10 Finland
Other specified papulosquamous disorders
422.2
70.2
68
*
L44.9
ICD-10 Finland
Papulosquamous disorder, unspecified
+∞
52.4
49
*
6970A
ICD-9 Finland
Lichen planus[LICHEN RUBER PLANUS]
+∞
52.4
49
*
D05BB02
ATC
acitretin; oral
76.4
52.0
58
9
D07AC01
ATC
betamethasone; topical
4.8
42.1
202
755
L44.2
ICD-10 Finland
Lichen striatus
+∞
40.4
38
*
L40.0
ICD-10 Finland
Psoriasis vulgaris
62.4
38.3
44
8
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.2
36.2
96
172
L44.1
ICD-10 Finland
Lichen nitidus
+∞
32.8
31
*
D07XC01
ATC
betamethasone, combinations; topical
6.7
32.5
91
174
E0000UV
ATC
NA
3.8
30.9
207
952
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.6
28.3
116
339
D07AC13
ATC
mometasone; topical
3.5
25.5
155
632
D07AD01
ATC
clobetasol; topical
4.6
25.1
98
269
D05AX52
ATC
calcipotriol, combinations; topical
12.4
24.7
45
41
L43.8
ICD-10 Finland
Other lichen planus
66.9
22.1
25
*
D07AB02
ATC
hydrocortisone butyrate; topical
2.9
18.0
140
641
L44.3
ICD-10 Finland
Lichen ruber moniliformis
+∞
17.9
17
*
D07AB08
ATC
desonide; topical
4.4
17.4
68
182
D05AX02
ATC
calcipotriol; topical
11.6
17.3
32
30
E000001
ATC
NA
3.1
16.8
114
473
TQW80
NOMESCO Finland
Local dermatologic skincare
10.4
14.5
28
29
L26
ICD-10 Finland
Exfoliative dermatitis
145.2
13.5
14
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
145.2
13.5
14
*
E000003
ATC
NA
6.1
13.2
36
64
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.1
12.5
50
136
E000002
ATC
NA
3.3
12.4
68
239
L43.9
ICD-10 Finland
Lichen planus, unspecified
18.9
12.2
18
10
D02AE01
ATC
carbamide; topical
4.8
11.6
39
89
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
11.5
11
*
D07AA02
ATC
hydrocortisone; topical
3.0
11.2
71
275
H02AB06
ATC
prednisolone; systemic
2.2
11.0
174
1088
134
Kela drug reimbursment
General erythroderma
113.2
10.5
11
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
24.2
10.3
14
6
L40.5
ICD-10 Finland
Arthropathic psoriasis
41.3
10.0
12
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.4
9.7
93
455
L40.8
ICD-10 Finland
Other psoriasis
46.0
7.7
9
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.8
7.6
49
192
R06AE07
ATC
cetirizine; oral
1.9
7.5
161
1084
69698
ICD-8 Finland
Psoriasis and similar disorders, Other disorders
+∞
7.3
7
*
L40
ICD-10 Finland
Psoriasis
14.1
6.9
11
8
D07AB01
ATC
clobetasone; topical
4.5
6.9
23
54
A46
ICD-10 Finland
Erysipelas
2.4
6.7
55
248
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.9
6.6
41
155
D07BC01
ATC
betamethasone and antiseptics; topical
2.6
6.6
46
190
L20.0
ICD-10 Finland
Besnier prurigo
3.1
6.6
35
122
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.2
6.4
23
58
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
18.4
6.3
9
5
69700
ICD-8 Finland
Lichen, Planus
+∞
6.3
6
*
69699
ICD-8 Finland
NA
+∞
6.3
6
*
M07.3
ICD-10 Finland
Other psoriatic arthropathies
+∞
6.3
6
*
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
6.3
6
*
M25.5
ICD-10 Finland
Pain in joint
1.9
6.2
105
639
XQ848
NOMESCO Finland
Dermatological photography
5.4
6.1
17
33

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
50
124
4.47
18.90
1.9
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
233
1551
2.21
13.27
9.5
5.3
e9/l
0.6
0.6
1.03
210
1350
(3019198) Lymphocytes [#/volume] in Blood
238
1601
2.21
13.16
9.4
5.3
e9/l
2.1
2.0
0.18
216
1424
(3006315) Basophils [#/volume] in Blood
233
1557
2.20
13.07
9.6
5.3
e9/l
0.0
0.0
0.58
210
1358
(3013650) Neutrophils [#/volume] in Blood by Automated count
259
1819
2.21
12.63
12.8
8.6
e9/l
4.3
4.1
0.81
231
1587
(3013115) Eosinophils [#/volume] in Blood
236
1607
2.15
12.34
10.1
5.5
e9/l
0.2
0.2
1.37
216
1418
(42870588) Differential panel, method unspecified - Blood
164
1024
2.02
10.27
9.3
5.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
216
1509
1.94
9.56
10.1
5.5
%
28.9
28.5
0.24
205
1422
(3037522) Nuclear Ab [Titer] in Serum
82
406
2.28
9.26
1.5
1.3
titre
352.9
493.5
0.41
17
86
(3019069) Monocytes/100 leukocytes in Blood
210
1467
1.91
9.16
10.5
5.7
%
8.5
8.4
0.29
201
1386
(3006504) Eosinophils/100 leukocytes in Blood
209
1459
1.91
9.13
10.2
5.4
%
3.1
2.8
1.26
201
1362
(3018010) Neutrophils/100 leukocytes in Blood
211
1486
1.89
8.89
9.7
5.3
%
55.5
56.5
0.56
200
1404
(3022096) Basophils/100 leukocytes in Blood
203
1413
1.89
8.86
10.3
5.5
%
0.7
0.6
0.41
195
1324
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
187
1269
1.89
8.81
2.5
2.3
nmol/l
78.0
75.8
0.52
172
1144
(3036481) Cortisol [Moles/volume] in Serum or Plasma
62
288
2.37
8.06
2.8
2.0
nmol/l
307.6
369.2
1.57
57
269
(3024561) Albumin [Mass/volume] in Serum or Plasma
180
1256
1.79
7.38
5.9
4.9
g/l
35.6
35.6
0.05
166
1178
(3007853) Bacteria identified in Skin by Aerobe culture
67
341
2.16
6.98
2.2
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
125
799
1.82
6.74
9.9
6.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
124
794
1.82
6.63
2.8
2.0
mg/l
3.0
3.0
0.02
109
679
(4062490)
14
29
4.97
6.50
1.2
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
79
439
2.00
6.50
2.9
2.2
g/l
2.3
2.4
0.39
74
403
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
291
2388
1.81
6.39
9.5
7.2
u/l
79.5
79.8
0.04
277
2234
(40760892) CBC W Ordered Manual Differential panel - Blood
112
707
1.81
6.23
6.2
4.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
51
243
2.26
6.23
2.9
2.6
g/l
66.5
67.0
0.20
44
223
(3000494) Fungus identified in Specimen by Culture
68
366
2.03
6.09
1.8
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
80
3.13
5.91
1.5
1.3
ug/g
260.5
305.1
0.43
13
43
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
73
413
1.94
5.67
3.0
2.3
%
22.3
22.6
0.05
66
359
(3027945) Reticulocytes/100 erythrocytes in Blood
63
340
2.01
5.59
4.3
2.7
%
1.9
1.8
0.44
55
305
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
289
2416
1.72
5.39
4.7
3.9
pmol/l
14.9
14.7
0.56
259
2175
(4027681)
10
18
5.67
5.35
1.4
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
197
1504
1.61
5.20
6.8
6.5
mmol/l
1.2
1.2
0.62
172
1285
(3007164) IgA [Mass/volume] in Serum or Plasma
103
666
1.74
5.17
2.1
1.4
g/l
2.3
2.3
0.06
69
393
(3017181) Myelocytes/100 leukocytes in Blood
49
250
2.09
5.05
5.1
3.8
%
2.3
1.1
0.53
15
84
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
165
1218
1.61
4.94
2.2
1.9
pmol/l
101.5
95.5
0.73
95
634
(3021440) Promyelocytes/100 leukocytes in Blood
46
232
2.11
4.89
5.3
3.9
%
0.4
0.2
0.46
15
76
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
155
1131
1.61
4.84
3.9
3.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
184
1400
1.58
4.81
12.6
9.1
e9/l
0.0
0.0
0.24
158
1148
(3000850) Epithelial cells [#/volume] in Urine
102
670
1.70
4.81
3.0
2.6
e6/l
5.4
5.7
0.09
95
598
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
52
3.37
4.80
2.9
3.3
e9/l
4.7
4.4
0.24
17
52
(3002582) Erythrocytes [#/volume] in Urine
137
973
1.62
4.77
3.7
3.2
e6/l
12.2
122.7
1.02
111
752
(3002179) Metamyelocytes/100 leukocytes in Blood
44
221
2.11
4.73
4.8
3.8
%
0.1
0.4
—
8
55
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
53
3.31
4.67
3.1
3.5
%
59.8
58.9
0.10
17
53
(3009261) Glucose [Presence] in Urine by Test strip
199
1550
1.57
4.65
4.3
3.7
estimate
0.0
0.0
0.00
30
293
(3023520) Reticulocytes [#/volume] in Blood
47
245
2.04
4.58
2.9
2.5
e9/l
68.6
69.6
0.08
34
191
(3023368) Bacteria identified in Blood by Culture
117
813
1.62
4.40
5.2
4.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
276
2333
1.60
4.39
5.8
3.9
mm/h
12.3
11.5
0.46
255
2144
(3004588) Protein electrophoresis panel - Serum or Plasma
40
201
2.10
4.30
3.3
2.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
9
9.04
4.30
1.4
1.0
ug/l
9.4
9.6
—
8
9
(3018095) Leukocytes [#/volume] in Urine
153
1138
1.56
4.29
4.5
3.7
e6/l
32.9
67.9
1.46
120
809
(3035350) Ketones [Presence] in Urine by Test strip
195
1531
1.54
4.28
4.2
3.7
estimate
0.0
0.0
0.00
33
302
(3000991) Gas panel - Venous blood
48
259
1.97
4.26
8.0
7.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
195
1533
1.53
4.24
5.8
5.0
estimate
0.0
0.0
0.00
33
302
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
129
926
1.58
4.21
2.5
2.0
u/l
150.0
212.3
1.18
124
874
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
205
1634
1.53
4.15
6.3
6.2
umol/l
11.0
11.3
0.11
190
1538
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
178
1377
1.53
4.14
6.7
5.7
mmol/l
1.2
1.2
0.43
167
1248
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
33
156
2.22
4.13
3.2
3.4
mmol/l
24.5
24.1
0.26
25
143
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
107
743
1.60
3.99
1.5
1.3
u/ml
0.8
2.1
1.05
33
186
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
207
2.04
3.99
1.9
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
123
892
1.55
3.78
3.7
3.1
e6/l
0.2
0.4
1.07
99
676
(36304419) Bacteria [Presence] in Urine
120
866
1.55
3.77
3.5
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
51
293
1.85
3.76
3.5
3.6
mmol/l
2.1
2.0
0.10
42
220
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
326
2913
1.66
3.70
5.7
4.6
mu/l
1.9
1.9
0.22
303
2651
(3011397) Hemoglobin [Presence] in Urine by Test strip
100
695
1.59
3.69
4.6
3.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
12
6.78
3.69
2.9
1.6
u/ml
810.9
987.0
—
8
12
(3026493) Urate [Moles/volume] in Serum or Plasma
110
782
1.56
3.68
3.2
2.7
umol/l
373.5
6439.1
3.31
95
671
(3001122) Ferritin [Mass/volume] in Serum or Plasma
182
1440
1.49
3.68
3.3
2.7
ug/l
97.2
104.0
0.35
165
1340
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
16
5.73
3.68
1.4
2.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
127
935
1.53
3.62
3.8
3.1
mmol/l
6.6
7.5
2.12
110
778
(3037467) Urinalysis macro (dipstick) panel - Urine
256
2173
1.50
3.61
4.9
4.2
—
—
—
0
0
(3012544) pH of Venous blood
52
305
1.81
3.60
3.4
3.6
—
—
—
0
0
(3026782) Osmolality of Urine
93
641
1.59
3.54
3.1
2.7
mosm/kgh2o
539.2
562.6
0.45
82
551
(3025159) Blasts/100 leukocytes in Blood
40
218
1.93
3.47
5.4
3.9
%
0.0
0.1
—
9
63
(3018418) pH of Serum or Plasma
122
901
1.51
3.40
4.2
3.7
ph
7.4
7.4
0.71
19
154
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
27
3.77
3.37
1.3
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
27
3.77
3.37
1.6
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
32
3.51
3.35
1.4
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
348
3188
1.73
3.29
20.1
13.6
mg/l
21.1
22.6
0.39
279
2508
(3020682) Albumin/Creatinine [Ratio] in Urine
121
899
1.50
3.26
4.8
3.9
mg/mmol
9.1
10.1
0.13
86
546
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
61
2.69
3.17
1.1
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
134
1023
1.47
3.13
3.6
3.2
mmol/l
2.3
2.3
0.25
119
898
(3025941) Bacteria identified in Stool by Culture
31
161
2.00
3.09
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
21
4.36
3.01
1.3
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
77
528
1.57
2.98
3.1
2.8
e6/l
0.9
1.1
0.27
43
292
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
108
2.20
2.97
3.6
2.0
g/l
10.1
10.3
0.09
18
97
(40768804) Tissue Pathology biopsy report
157
1246
1.43
2.96
2.6
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
303
2712
1.49
2.90
22.1
16.2
%
13.9
13.6
1.32
296
2670
(3013826) Glucose [Moles/volume] in Serum or Plasma
216
1819
1.41
2.88
5.5
4.6
mmol/l
6.8
6.6
0.44
204
1684
(3023323) Follitropin [Units/volume] in Serum or Plasma
25
124
2.08
2.83
1.3
1.6
iu/l
29.5
24.9
0.21
19
103
(3019309) Folate [Moles/volume] in Red Blood Cells
80
562
1.53
2.77
1.8
1.7
nmol/l
1163.5
1178.6
0.05
64
423
(3012516) Albumin [Mass/volume] in Urine
113
853
1.45
2.76
3.8
3.2
mg/l
56.6
297.5
1.10
80
534
(3012095) Magnesium [Moles/volume] in Serum or Plasma
72
495
1.55
2.75
3.1
3.5
mmol/l
0.8
0.8
0.91
66
462
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
89
641
1.50
2.75
1.7
1.7
pmol/l
462.7
451.9
0.09
74
533
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
92
2.24
2.72
1.5
2.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
10
6.07
2.70
1.2
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
100
743
1.46
2.64
1.6
1.6
nmol/l
18.7
20.7
0.74
91
634
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
21
100
2.16
2.64
5.2
2.3
g/l
0.8
1.0
0.17
16
92
(3048689) Calprotectin [Mass/mass] in Stool
61
408
1.58
2.62
3.6
1.9
ug/g
112.0
118.9
0.10
51
316
(3031040) Bacteria [#/volume] in Urine by Automated count
242
2103
1.38
2.55
5.4
4.4
e6/l
114.2
3905.2
—
5
34
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
219
1.76
2.52
1.2
1.3
iu/ml
133.0
150.3
0.14
18
84
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
76
2.29
2.47
1.1
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
76
541
1.50
2.47
2.9
2.9
mmol/l
2.4
2.4
1.83
66
476
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
358
3358
1.66
2.41
15.0
9.8
u/l
28.2
25.0
2.23
350
3234
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
118
2.01
2.40
4.7
2.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
84
2.20
2.38
2.3
2.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
52
2.55
2.38
3.8
2.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
17
78
2.23
2.34
1.1
1.3
—
2.6
—
0
10
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
124
977
1.39
2.34
3.5
2.5
u/l
68.6
58.0
0.35
110
913
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
345
1.58
2.32
1.3
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
76
550
1.47
2.28
1.4
1.3
iu/ml
26.0
41.0
0.62
19
179
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
516
1.48
2.27
1.4
1.3
u/ml
1.1
9.8
3.35
28
201
(3042936) Bacteria identified in Isolate by Culture
61
423
1.52
2.25
2.4
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
90
677
1.43
2.20
5.1
4.0
kg/l
1.0
1.0
0.22
13
99
(3037756) Immunofixation for Serum or Plasma
14
61
2.34
2.17
1.4
1.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
25
3.24
2.10
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
59
413
1.50
2.09
1.4
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
69
2.22
2.07
1.1
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
15
4.04
2.04
1.5
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
107
841
1.37
2.02
4.7
4.0
estimate
0.0
0.0
0.00
30
296
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
145
1195
1.34
2.01
4.7
3.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
32
2.85
2.01
2.4
3.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
127
1027
1.35
2.00
3.4
3.3
u/l
29.5
30.8
0.36
119
982
(3000492) Spirometry study
43
284
1.58
1.97
1.5
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
204
1.67
1.96
1.1
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
80
603
1.41
1.93
1.7
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
53
371
1.49
1.88
28.1
21.9
inr
1.1
1.3
—
6
51
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
34
2.68
1.87
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
14
66
2.16
1.84
1.0
1.3
—
40.3
—
0
8
(4035726)
39
257
1.57
1.82
1.7
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
47
2.38
1.79
1.3
1.5
—
—
—
0
0
(3020891) Body temperature
20
110
1.86
1.76
3.5
4.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
73
551
1.40
1.75
4.3
3.9
ng/l
296.9
225.3
0.15
55
424
(3045142) Bone marrow Pathology biopsy report
9
36
2.53
1.75
1.9
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
19
103
1.89
1.75
2.2
3.0
%
100.8
90.6
1.26
19
96
(36660697) Celiac disease serology panel - Serum
40
268
1.55
1.74
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
67
499
1.41
1.74
3.2
3.0
e6/l
2.4
2.6
0.06
34
266
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
315
2932
1.36
1.69
18.0
12.4
ml/min/173m2
85.1
82.4
1.24
267
2373
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
65
484
1.41
1.69
2.3
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
127
1.78
1.68
1.6
2.2
u/l
65.1
3704.4
—
7
49
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
76
2.01
1.66
1.7
1.6
iu/l
3.8
5.4
—
7
26
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
166
1.67
1.66
1.9
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
306
2844
1.33
1.60
7.2
5.5
mmol/mol
41.2
39.5
1.70
286
2656
(3020961) Endomysium IgA Ab [Titer] in Serum
26
160
1.67
1.60
1.3
1.1
—
104.2
—
0
5
(3019550) Sodium [Moles/volume] in Serum or Plasma
342
3235
1.41
1.58
20.9
15.5
mmol/l
139.4
139.7
1.21
330
3150
(3052851) Hemolysis interference index of Serum or Plasma
16
85
1.92
1.57
3.5
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
326
3061
1.36
1.57
5.3
4.2
mmol/l
4.6
4.6
0.59
306
2830
(3032080) INR in Blood by Coagulation assay
143
1212
1.28
1.55
6.8
8.8
inr
1.1
1.2
0.83
43
355
(3022145) Colonoscopy Study observation
46
327
1.46
1.54
1.6
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
36
243
1.53
1.54
3.6
3.4
—
—
—
0
0
(3004451) EKG impression Narrative
5
15
3.36
1.53
1.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
15
3.36
1.53
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
27
2.62
1.52
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
34
228
1.54
1.50
3.0
3.4
ng/l
142.2
74.1
0.96
29
209
(3023103) Potassium [Moles/volume] in Serum or Plasma
342
3242
1.39
1.49
21.0
15.6
mmol/l
4.0
4.0
1.11
330
3154
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
37
2.46
1.49
3.0
3.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
117
1.75
1.48
1.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
45
2.25
1.47
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
28
2.53
1.46
1.3
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
35
238
1.52
1.45
3.3
2.5
ml/min/173m2
72.8
67.2
0.34
18
96
(3003396) Base excess in Arterial blood by calculation
46
331
1.44
1.45
7.2
7.1
mmol/l
1.2
1.2
0.01
35
263
(40767503) Oxygen content in Capillary blood by calculation
12
59
2.07
1.45
2.9
2.7
%
17.8
16.1
—
7
26
(3006653) Thiamine [Moles/volume] in Blood
5
16
3.15
1.44
1.6
1.4
nmol/l
127.4
127.7
—
5
16
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
230
2077
1.25
1.43
3.1
3.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
315
1.45
1.43
4.0
3.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
298
0.59
1.42
1.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
96
1.81
1.41
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
63
482
1.36
1.41
1.4
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
40
2.28
1.41
3.4
14.1
mmol/l
5.4
6.4
—
9
33
(3032773) Endomysium IgG Ab [Titer] in Serum
7
29
2.44
1.40
1.7
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
29
2.44
1.40
3.1
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
138
1178
1.26
1.39
3.7
3.8
ng/l
36.8
41.3
0.17
84
815
(3015171) Extractable nuclear Ab [Units/volume] in Serum
19
112
1.73
1.38
1.2
1.3
u/ml
0.1
4.4
—
5
6
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
82
1.86
1.37
1.3
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
23
2.63
1.37
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
97
1.79
1.37
1.1
1.1
—
—
—
0
0
(4034850)
18
105
1.75
1.35
12.4
10.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
351
3353
1.40
1.35
23.0
15.6
umol/l
76.0
75.7
0.05
351
3353
(42529406) Shigella sp [Presence] in Stool by Culture
17
98
1.77
1.33
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
348
3322
1.38
1.32
16.1
12.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
24
2.52
1.31
1.3
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
34
2.38
1.30
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
62
1.96
1.29
1.2
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
18
2.80
1.29
1.0
1.2
iu/ml
201.8
115.1
—
5
18
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
18
2.80
1.29
1.8
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
18
2.80
1.29
1.8
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
55
2.03
1.28
1.5
1.1
u/ml
0.4
1.6
—
5
27
(3035637) Corticotropin [Mass/volume] in Plasma
8
35
2.31
1.27
1.8
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
35
2.31
1.27
1.3
1.9
ug/l
14.2
16.8
—
8
35
(3003327) Ova and parasites identified in Stool by Light microscopy
16
93
1.75
1.23
2.1
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
28
189
1.52
1.22
5.0
3.8
mmol/l
1.3
1.9
0.35
21
144
(3044290) Cell count panel - Cerebral spinal fluid
12
64
1.90
1.19
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
50
2.03
1.17
1.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
50
2.03
1.17
1.4
1.1
u/l
79.7
17.2
—
10
41
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
50
2.03
1.17
1.0
1.2
—
—
—
0
0
(3036489) Thrombin time
19
118
1.64
1.17
2.4
2.7
s
22.3
21.7
0.10
19
106
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.2
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
25
167
1.53
1.15
2.6
2.9
e6/l
0.2
0.2
0.06
25
162
(3007461) Platelets [#/volume] in Blood
368
3561
1.44
1.13
28.9
19.6
e9/l
255.4
250.0
0.77
356
3477
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
88
1.73
1.13
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
88
1.73
1.13
1.7
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
30
2.36
1.13
2.1
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
320
3037
1.27
1.12
5.1
4.3
mmol/l
6.2
5.9
2.27
293
2769
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
40
2.02
1.12
2.4
1.9
pg
35.4
32.5
—
8
40
(3044889) 12 lead EKG panel
232
2129
1.22
1.12
3.9
3.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
96
1.69
1.12
1.8
2.3
u/ml
0.4
0.4
—
7
53
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
331
1.37
1.11
2.0
1.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
368
3563
1.44
1.11
28.8
19.5
pg
30.3
30.2
0.09
360
3516
(3024731) MCV [Entitic volume]
368
3563
1.44
1.11
28.9
19.5
fl
91.1
90.8
0.66
360
3517
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
112
1.64
1.11
1.6
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
66
1.84
1.10
1.7
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
66
1.84
1.10
1.7
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
368
3564
1.43
1.09
29.0
19.6
e12/l
4.5
4.5
0.07
356
3468
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
21
2.40
1.09
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
32
2.21
1.08
3.7
2.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
59
1.89
1.08
1.5
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
368
3565
1.43
1.08
29.0
19.6
e9/l
7.1
6.7
2.10
356
3461
(3000963) Hemoglobin [Mass/volume] in Blood
368
3567
1.42
1.05
29.0
19.6
g/l
134.9
134.9
0.02
361
3516
(3008898) HLA-B27 [Presence]
20
130
1.57
1.05
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
103
877
1.24
1.04
3.0
3.2
ng/l
792.1
1369.2
2.37
90
751
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
83
690
1.26
1.04
1.9
1.9
mg/l
1.6
1.2
0.72
63
534
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
60
1.86
1.04
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
320
3046
1.26
1.03
4.8
4.2
mmol/l
1.4
1.5
3.38
297
2798
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
400
0.70
1.03
5.3
4.4
%
32.5
31.9
0.12
23
260
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
53
1.91
1.02
1.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
48
1.89
1.01
1.2
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
337
1.34
1.01
1.9
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
159
0.56
1.00
1.7
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
148
1.51
1.00
4.6
3.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
61
1.83
0.99
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
50
393
1.31
0.97
1.9
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
113
979
1.22
0.97
3.0
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
70
1.74
0.93
1.1
1.3
—
—
—
0
0
(4010399)
32
236
1.39
0.93
1.7
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
308
2931
1.22
0.93
4.8
3.8
mmol/l
1.4
1.3
2.28
285
2680
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
53
424
1.29
0.91
2.1
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
345
0.71
0.91
1.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
104
0.47
0.90
1.2
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
28
203
1.41
0.90
5.3
3.6
kpa
5.2
5.1
0.40
28
190
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
44
1.83
0.86
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
80
1.65
0.85
1.2
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
29
214
1.38
0.85
2.7
2.8
ng/l
85.6
189.5
2.24
24
195
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
31
1.95
0.84
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
180
1.41
0.84
1.1
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
227
2115
1.17
0.82
3.6
3.1
u/l
54.7
43.9
1.16
212
1979
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
32
1.89
0.82
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
85
728
1.21
0.82
2.9
2.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
325
3122
1.22
0.82
5.7
4.7
mmol/l
2.7
2.7
0.45
303
2864
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
11
66
1.69
0.79
2.0
2.3
ug/min
153.5
130.9
—
5
33
(1617658) Protocol used for examination of sentinel lymph nodes
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
25
0.00
0.79
0.0
3.4
—
60.9
—
0
25
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
197
0.65
0.77
1.3
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
15
100
1.52
0.74
1.5
1.6
mu/l
224.6
305.8
1.42
15
89
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
160
1461
1.16
0.73
4.2
4.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
56
1.62
0.73
3.0
2.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
99
871
1.18
0.72
3.4
3.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
57
1.59
0.71
6.7
3.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
37
293
1.29
0.71
2.6
2.4
u/l
31.3
30.8
0.05
30
248
(40760888) Immunoglobulin light chains.free panel - Serum
9
58
1.56
0.70
6.7
4.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
26
196
1.35
0.69
1.2
1.3
—
39.7
—
0
12
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
77
1.58
0.69
1.8
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
42
1.68
0.68
1.0
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
307
2951
1.18
0.67
20.3
13.9
%
39.5
40.0
0.51
219
2193
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
77
668
1.19
0.66
1.7
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
107
959
1.16
0.62
4.5
3.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
28
218
1.31
0.62
2.2
2.4
—
15.0
—
0
9
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
50
1.61
0.61
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
51
1.58
0.60
2.0
1.8
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
20
0.00
0.60
0.0
1.2
—
1.1
—
0
7
(3015183) Erythrocyte sedimentation rate
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
149
1.36
0.59
12.9
8.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
17
123
1.40
0.59
1.4
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
53
1.52
0.58
1.8
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
35
1.72
0.58
1.2
1.0
—
—
—
0
0
(1002224) Polysomnography panel
17
125
1.38
0.54
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
61
1.49
0.54
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
18
134
1.36
0.54
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
134
1.36
0.54
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
100
1.41
0.52
1.5
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
92
827
1.15
0.52
2.0
1.6
mmol/l
1.5
1.3
1.36
78
699
(3019060) Gas panel - Arterial blood
24
189
1.29
0.51
2.5
3.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
136
1.34
0.50
1.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
277
0.78
0.48
1.6
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
46
1.53
0.48
1.1
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
47
1.50
0.48
3.4
2.2
%
68.8
59.0
—
7
47
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
191
1.27
0.47
1.5
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
48
1.47
0.47
7.0
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
48
1.47
0.47
1.0
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
9
131
0.68
0.43
2.4
3.0
u/ml
33.3
2219.5
—
9
112
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
16
0.00
0.41
0.0
1.1
—
7.2
—
0
16
(3036071) Salmonella sp Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
132
1.30
0.41
1.9
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
34
1.48
0.40
1.8
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
10
137
0.72
0.39
2.2
1.6
mg/l
2.1
3.2
—
5
96
(3042631) Mycobacterium sp identified in Specimen
5
35
1.43
0.39
2.2
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
115
1.32
0.39
3.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
107
1.32
0.37
1.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
100
925
1.11
0.36
4.7
5.0
ug/l
5.0
2.8
0.43
90
809
(3027944) Amphetamines [Presence] in Urine
17
135
1.27
0.36
1.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
42
1.43
0.35
2.2
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
80
0.62
0.35
1.2
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
44
1.37
0.34
2.5
2.7
mmol/l
3.9
4.0
—
6
44
(3035285) Chloride [Moles/volume] in Venous blood
6
44
1.37
0.34
2.5
2.7
mmol/l
104.3
106.6
—
6
44
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
45
1.34
0.34
1.8
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
88
0.68
0.33
1.8
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.8
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.8
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
120
1.26
0.30
3.3
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
93
1.30
0.30
1.5
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
196
1.18
0.27
4.8
2.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
67
1.20
0.26
3.9
2.4
g/l
138.4
129.7
—
8
50
(1761482) Bacteria [#/volume] in Urine by Culture
11
86
1.29
0.26
3.1
4.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
16
132
1.22
0.26
5.1
4.2
mmol/l
24.3
25.0
0.48
16
125
(3013512) EKG study
84
897
0.92
0.26
4.2
3.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
75
1.20
0.25
1.6
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
20
170
1.19
0.25
4.7
2.8
u/ml
19.9
35.7
1.13
20
161
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
96
1.26
0.25
1.8
1.5
—
—
—
0
0
(44790047)
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(44806118)
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(44790048)
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(44790049)
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
38
1.32
0.23
11.2
4.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
41
1.22
0.22
1.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
182
1.16
0.22
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
552
0.91
0.21
3.4
3.0
ug/l
0.6
0.8
0.55
35
362
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
177
0.84
0.21
1.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
43
1.16
0.21
1.2
1.9
%
88.1
90.0
—
5
43
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.3
—
5202.4
—
0
7
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.2
—
336.0
—
0
8
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
48
1.25
0.20
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
48
1.25
0.20
1.8
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
156
1.16
0.19
3.6
3.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
48
517
0.92
0.18
1.8
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
59
1.19
0.18
2.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
152
0.85
0.17
1.4
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
67
0.74
0.17
1.8
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
8
69
1.16
0.16
7.5
4.5
mg/l
14.7
24.8
—
8
45
(4094501)
8
73
1.10
0.16
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
78
0.77
0.15
1.8
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
78
0.77
0.15
1.8
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
78
0.77
0.15
1.8
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
78
0.77
0.15
1.8
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
79
1.14
0.15
1.3
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
243
0.90
0.14
1.8
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
23
209
1.11
0.13
3.5
2.5
e9/l
4.0
4.0
0.02
18
168
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
77
738
1.05
0.13
4.5
4.3
%
21.8
21.3
0.08
33
344
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
191
1.11
0.12
1.7
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
86
1.17
0.11
1.3
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
29
270
1.08
0.11
4.6
3.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
31
331
0.93
0.10
1.7
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
44
1.14
0.10
2.8
2.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
64
0.78
0.08
1.8
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
64
0.78
0.08
1.8
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.3
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
107
1093
0.97
0.07
3.4
2.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
80
0.87
0.07
1.3
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
89
1.13
0.07
1.9
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
110
0.91
0.05
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
38
389
0.97
0.02
1.5
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
162
0.99
0.00
2.4
2.4
—
—
—
0
0
(3019225) pH of Specimen
30
298
1.01
0.00
3.9
4.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
35
348
1.01
0.00
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
37
372
0.99
0.00
6.5
6.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
117
1.03
0.00
2.3
2.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
26
263
0.99
0.00
2.7
2.4
ug/l
7.5
8.2
0.07
26
228
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
313
0.99
0.00
3.7
4.3
ug/l
18.6
22.2
0.08
24
259
(3003694) ABO and Rh group [Type] in Blood
88
885
0.99
0.00
1.5
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
41.0
—
0
5
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
3.2
—
0
5
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
1.6
—
3695.6
—
0
5
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
2.2
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
67
0.89
0.00
2.2
2.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
60
1.00
0.00
1.0
1.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
16.0
—
0
6
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
110
1.00
0.00
1.5
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PAPULOSQUAOTH and mortality.

Females

Parameter HR [95% CI] p-value
L12_PAPULOSQUAOTH 1.183 [0.96, 1.46] 0.119
Birth year 0.99 [0.98, 1.0] 0.027

During the follow-up period (1.1.1998 — 31.12.2019), 164 out of 1235 females with L12_PAPULOSQUAOTH died.

Males

Parameter HR [95% CI] p-value
L12_PAPULOSQUAOTH 1.496 [1.14, 1.97] 0.004
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 184 out of 1017 males with L12_PAPULOSQUAOTH died.

Mortality risk

Mortality risk for people of age

years, who have L12_PAPULOSQUAOTH.

N-year risk Females Males
1 0.083% 0.332%
5 0.566% 1.753%
10 1.522% 4.204%
15 2.952% 7.479%
20 5.118% 12.236%

Relationships between endpoints

↥

Index endpoint: L12_PAPULOSQUAOTH – Other papulosquamous disorders

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data